Tiroid Kanserlerinde Patoloji

Di Pasquale M, Rothstein JL, Palazzo JP. Pathologic features of Hashimoto’s- associated papillary thyroid carcinomas. Hum Pathol. 2001;32(1):24-30.

Janjua N, Wreesmann VB. Aggressive differentiated thyroid cancer. Eur J Surg Oncol. 2018;44(3):367-

Falvo L, D’Ercole C, Sorrenti S, et al. Papillary microcarcinoma of the thyroid gland: analysis of prognostic factors including histological subtype. Eur J Surg Suppl. 2003(588):28-32.

Baloch ZW, LiVolsi VA. Microcarcinoma of the thyroid. Adv Anat Pathol. 2006;13(2):69-75.

Tielens ET, Sherman SI, Hruban RH. Follicular variant of papillary thyroid carcinoma. A clinicopathologic study. Cancer. 1994;73(2):424-431.

Thompson LD. Ninety-four cases of encapsulated follicular variant of papillary thyroid carcinoma: a name change to noninvasive follicular thyroid neoplasm with papillary-like nuclear features would help prevent overtreatment. ModPathol. 2016;29(7):698-707.

Matos PS, Ferreira AP, de Oliveira Facuri F. Usefulness of HBME-1, cytokeratin 19 and galectin-3 immunostaining in the diagnosis of thyroid malignancy. Histopathology. 2005;47(4):391-401.

Vivero M, Kraft S, Barletta JA. Risk stratification of follicular variant of papillary thyroid carcinoma. Thyroid. 2013;23(3):273-279.

Piana S, Frasoldati A, Di Felice E. Encapsulated well-differentiated follicular-patterned thyroid carcinomas do not play a significant role in the fatality rates from thyroid carcinoma. Am J Surg Pathol. 2010;34(6):868-872.

Liu J, Singh B, Tallini G, et al. Follicular variant of papillary thyroid carcinoma: a clinicopathologic study of a problematic entity. Cancer. 2006;107(6):1255- 1264.

Seethala RR, Baloch ZW, Barletta JA, et al. Noninvasive follicular thyroid neoplasm with papillary-like nuclear features: a review for pathologists. Mod Pathol. 2018;31(1):39-55.

Nikiforov YE, Seethala RR, Tallini G, et al. Nomenclature revision for encapsulated follicular variant of papillary thyroid carcinoma: a paradigm shift to reduce overtreatment of indolent tumors. JAMA Oncol. 2016;2(8):1023- 1029.

Xu B, Tallini G, Scognamiglio T. Outcome of large noninvasive follicular thyroid neoplasm with papillary-like nuclear features. Thyroid. 2017;27(4):512-517.

Thompson LD, Wieneke JA, Paal E. A clinicopathologic study of minimally invasive follicular carcinoma of the thyroid gland with a review of the English literature. Cancer. 2001;91(3):505-524.

LiVolsi VA, Asa SL. The demise of follicular carcinoma of the thyroid gland. Thyroid. 1994;4(2):233-236.

Baloch ZW, Livolsi VA. Follicular-patterned lesions of the thyroid: the bane of the pathologist. Am J Clin Pathol. 2002;117(1):143-150.

Evans HL. Follicular neoplasms of the thyroid. A study of 44 cases followed for a minimum of 10 years, with emphasis on differential diagnosis. Cancer. 1984;54(3):535-540.

Pal P, Singh B, Kane S. Bone metastases in follicular carcinoma of thyroid. Indian J Otolaryngol Head Neck Surg. 2018;70(1):10- 14.

Clark OH, Fredrickson JM, Harvey HK. Thyroid mass. Head Neck. 1993;15(6):574-579.

Thompson NW, Dunn EL, Batsakis JG. Hurthle cell lesions of the thyroid gland. Surg Gynecol Obstet. 1974;139(4):555-560.

Watson RG, Brennan MD, Goellner JR, van Heerden JA, McConahey WM, Taylor WF. Invasive Hurthle cell carcinoma of the thyroid: natural history and management. Mayo Clin Proc. 1984;59(12):851-855.

Grani G, Lamartina L, Durante C. Follicular thyroid cancer and Hurthle cell carcinoma: challenges in diagnosis, treatment, and clinical management. Lancet Diabetes Endocrinol. 2018;6(6):500-514.

Tollefson H, Shah J, Huvos A. Hürthle cell carcinoma of the thyroid. Am J Surg. 1975;130:390-394.

Heppe H, Armin A, Calandra DB, Lawrence AM, Paloyan E. Hurthle cell tumors of the thyroid gland. Surgery. 1985;98(6):1162-1165.

Shafique K, Baloch Z. Risk stratification of papillary thyroid carcinoma and its variants; from clinicopathologic features to molecular profiling. Diagn Histopathol. 2019;25(5):143-153.

Xu B, Fuchs T, Dogan S, et al. Dissecting anaplastic thyroid carcinoma: a comprehensive clinical, histologic, immunophenotypic, and molecular study of 360 cases. Thyroid. 2020;30(10):1505-1517.

Hvilsom GB, Londero SC, Hahn CH, et al. Anaplastic thyroid carcinoma in Denmark 1996-2012: a national prospective study of 219 patients. Cancer Epidemiol. 2018;53:65-71.

Deeken-Draisey A, Yang GY, Gao J. Anaplastic thyroid carcinoma: an epidemiologic, histologic, immunohistochemical, and molecular single-institution study. Hum Pathol. 2018;82:140-148.

Carcangiu ML, Steeper T, Zampi G. Anaplastic thyroid carcinoma. A study of 70 cases. Am J Clin Pathol. 1985;83(2):135-158.

Kobayashi S, Yamadori I, Ohmori M. Anaplastic carcinoma of the thyroid with osteoclast-like giant cells. An ultrastructural and immunohistochemical study. Acta Pathol Jpn. 1987;37(5):807-815.

Brutsaert EF, Gersten AJ, Tassler AB. Medullary thyroid cancer with undetectable serum calcitonin. J Clin Endocrinol Metab. 2015;100(2):337- 341.

Kasajima A, Cameselle-Teijeiro J, Loidi L, et al. A calcitonin non-producing neuroendocrine tumor of the thyroid gland. Endocr Pathol. 2016;27(4):325- 331.

Komminoth P, Roth J, Saremaslani P. Polysialic acid of the neural cell adhesion molecule in the human thyroid: a marker for medullary thyroid carcinoma and primary C-cell hyperplasia. An immunohistochemical study on 79 thyroid lesions. Am J Surg Pathol. 1994;18(4):399-411.

Roman S, Lin R, Sosa JA. Prognosis of medullary thyroid carcinoma: demographic, clinical, and pathologic predictors of survival in 1252 cases. Cancer. 2006;107(9):2134-2142.

Randolph GW, Maniar D. Medullary carcinoma of the thyroid. Cancer Control. 2000;7(3):253-261.

Hale PM, Ali AK, Buse JB, et al. Medullary thyroid carcinoma surveillance study: a case-series registry. Thyroid. 2020;30(10):1397-1398.

Spanheimer PM, Ganly I, Chou J, et al. Long-term oncologic outcomes after curative resection of familial medullary thyroid carcinoma. Ann Surg Oncol. 2019;26(13):4423-4429.

Di Pasquale M, Rothstein JL, Palazzo JP. Pathologic features of Hashimoto’s- associated papillary thyroid carcinomas. Hum Pathol. 2001;32(1):24-30.

Janjua N, Wreesmann VB. Aggressive differentiated thyroid cancer. Eur J Surg Oncol. 2018;44(3):367-

Falvo L, D’Ercole C, Sorrenti S, et al. Papillary microcarcinoma of the thyroid gland: analysis of prognostic factors including histological subtype. Eur J Surg Suppl. 2003(588):28-32.

Baloch ZW, LiVolsi VA. Microcarcinoma of the thyroid. Adv Anat Pathol. 2006;13(2):69-75.

Tielens ET, Sherman SI, Hruban RH. Follicular variant of papillary thyroid carcinoma. A clinicopathologic study. Cancer. 1994;73(2):424-431.

Thompson LD. Ninety-four cases of encapsulated follicular variant of papillary thyroid carcinoma: a name change to noninvasive follicular thyroid neoplasm with papillary-like nuclear features would help prevent overtreatment. ModPathol. 2016;29(7):698-707.

Matos PS, Ferreira AP, de Oliveira Facuri F. Usefulness of HBME-1, cytokeratin 19 and galectin-3 immunostaining in the diagnosis of thyroid malignancy. Histopathology. 2005;47(4):391-401.

Vivero M, Kraft S, Barletta JA. Risk stratification of follicular variant of papillary thyroid carcinoma. Thyroid. 2013;23(3):273-279.

Piana S, Frasoldati A, Di Felice E. Encapsulated well-differentiated follicular-patterned thyroid carcinomas do not play a significant role in the fatality rates from thyroid carcinoma. Am J Surg Pathol. 2010;34(6):868-872.

Liu J, Singh B, Tallini G, et al. Follicular variant of papillary thyroid carcinoma: a clinicopathologic study of a problematic entity. Cancer. 2006;107(6):1255- 1264.

Seethala RR, Baloch ZW, Barletta JA, et al. Noninvasive follicular thyroid neoplasm with papillary-like nuclear features: a review for pathologists. Mod Pathol. 2018;31(1):39-55.

Nikiforov YE, Seethala RR, Tallini G, et al. Nomenclature revision for encapsulated follicular variant of papillary thyroid carcinoma: a paradigm shift to reduce overtreatment of indolent tumors. JAMA Oncol. 2016;2(8):1023- 1029.

Xu B, Tallini G, Scognamiglio T. Outcome of large noninvasive follicular thyroid neoplasm with papillary-like nuclear features. Thyroid. 2017;27(4):512-517.

Thompson LD, Wieneke JA, Paal E. A clinicopathologic study of minimally invasive follicular carcinoma of the thyroid gland with a review of the English literature. Cancer. 2001;91(3):505-524.

LiVolsi VA, Asa SL. The demise of follicular carcinoma of the thyroid gland. Thyroid. 1994;4(2):233-236.

Baloch ZW, Livolsi VA. Follicular-patterned lesions of the thyroid: the bane of the pathologist. Am J Clin Pathol. 2002;117(1):143-150.

Evans HL. Follicular neoplasms of the thyroid. A study of 44 cases followed for a minimum of 10 years, with emphasis on differential diagnosis. Cancer. 1984;54(3):535-540.

Pal P, Singh B, Kane S. Bone metastases in follicular carcinoma of thyroid. Indian J Otolaryngol Head Neck Surg. 2018;70(1):10- 14.

Clark OH, Fredrickson JM, Harvey HK. Thyroid mass. Head Neck. 1993;15(6):574-579.

Thompson NW, Dunn EL, Batsakis JG. Hurthle cell lesions of the thyroid gland. Surg Gynecol Obstet. 1974;139(4):555-560.

Watson RG, Brennan MD, Goellner JR, van Heerden JA, McConahey WM, Taylor WF. Invasive Hurthle cell carcinoma of the thyroid: natural history and management. Mayo Clin Proc. 1984;59(12):851-855.

Grani G, Lamartina L, Durante C. Follicular thyroid cancer and Hurthle cell carcinoma: challenges in diagnosis, treatment, and clinical management. Lancet Diabetes Endocrinol. 2018;6(6):500-514.

Tollefson H, Shah J, Huvos A. Hürthle cell carcinoma of the thyroid. Am J Surg. 1975;130:390-394.

Heppe H, Armin A, Calandra DB, Lawrence AM, Paloyan E. Hurthle cell tumors of the thyroid gland. Surgery. 1985;98(6):1162-1165.

Shafique K, Baloch Z. Risk stratification of papillary thyroid carcinoma and its variants; from clinicopathologic features to molecular profiling. Diagn Histopathol. 2019;25(5):143-153.

Xu B, Fuchs T, Dogan S, et al. Dissecting anaplastic thyroid carcinoma: a comprehensive clinical, histologic, immunophenotypic, and molecular study of 360 cases. Thyroid. 2020;30(10):1505-1517.

Hvilsom GB, Londero SC, Hahn CH, et al. Anaplastic thyroid carcinoma in Denmark 1996-2012: a national prospective study of 219 patients. Cancer Epidemiol. 2018;53:65-71.

Deeken-Draisey A, Yang GY, Gao J. Anaplastic thyroid carcinoma: an epidemiologic, histologic, immunohistochemical, and molecular single-institution study. Hum Pathol. 2018;82:140-148.

Carcangiu ML, Steeper T, Zampi G. Anaplastic thyroid carcinoma. A study of 70 cases. Am J Clin Pathol. 1985;83(2):135-158.

Kobayashi S, Yamadori I, Ohmori M. Anaplastic carcinoma of the thyroid with osteoclast-like giant cells. An ultrastructural and immunohistochemical study. Acta Pathol Jpn. 1987;37(5):807-815.

Brutsaert EF, Gersten AJ, Tassler AB. Medullary thyroid cancer with undetectable serum calcitonin. J Clin Endocrinol Metab. 2015;100(2):337- 341.

Kasajima A, Cameselle-Teijeiro J, Loidi L, et al. A calcitonin non-producing neuroendocrine tumor of the thyroid gland. Endocr Pathol. 2016;27(4):325- 331.

Komminoth P, Roth J, Saremaslani P. Polysialic acid of the neural cell adhesion molecule in the human thyroid: a marker for medullary thyroid carcinoma and primary C-cell hyperplasia. An immunohistochemical study on 79 thyroid lesions. Am J Surg Pathol. 1994;18(4):399-411.

Roman S, Lin R, Sosa JA. Prognosis of medullary thyroid carcinoma: demographic, clinical, and pathologic predictors of survival in 1252 cases. Cancer. 2006;107(9):2134-2142.

Randolph GW, Maniar D. Medullary carcinoma of the thyroid. Cancer Control. 2000;7(3):253-261.

Hale PM, Ali AK, Buse JB, et al. Medullary thyroid carcinoma surveillance study: a case-series registry. Thyroid. 2020;30(10):1397-1398.

Spanheimer PM, Ganly I, Chou J, et al. Long-term oncologic outcomes after curative resection of familial medullary thyroid carcinoma. Ann Surg Oncol. 2019;26(13):4423-4429.